Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8508881 | 0.82 | KMT2A (0.48) | — | |
| SCHEMBL8509902 | 0.82 | ATAD2 (0.33) | ATAD2DPYD | |
| SCHEMBL17060269 | 0.77 | DPYD (0.52) | ATAD2DPYD | |
| SCHEMBL2043942 | 0.77 | DPYD (0.52) | ATAD2DPYD | |
| SCHEMBL161148 | 0.76 | ATAD2 (0.54) | ATAD2DPYD | |
| SCHEMBL2584919 | 0.74 | LMNA (0.52) | ATAD2DPYD | |
| SCHEMBL4353311 | 0.73 | DPYD (0.50) | ATAD2DPYD | |
| SCHEMBL5800398 | 0.73 | — | — | |
| SCHEMBL4794144 | 0.73 | ATAD2 (0.47) | ATAD2DPYD | |
| SCHEMBL5962348 | 0.73 | ATAD2 (0.47) | ATAD2DPYD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2001522860-A | — | — | 2001-11-20 | — | — | JP | claimed |
| EP-1027364-A2 | PYRIMIDINE DERIVATIVES FOR LABELED BINDING PARTNERS | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-16 | — | — | EP | claimed |
| WO-1999024452-A9 | PYRIMIDINE DERIVATIVES FOR LABELED BINDING PARTNERS | ISIS PHARMACEUTICALS INC (US) | 1999-08-12 | — | — | WO | claimed |
| WO-1999024452-A2 | PYRIMIDINE DERIVATIVES FOR LABELED BINDING PARTNERS | ISIS PHARMACEUTICALS, INC. (US) | 1999-05-20 | — | — | WO | claimed |
| CN-106566855-B | Nucleic acid amplification using reversibly modified oligonucleotides | 苏州新海生物科技股份有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-106566855-A | Nucleic acid amplification using reversibly modified oligonucleotide | 毕万里 | 2017-04-19 | — | — | CN | disclosed |
| CN-101495657-B | Nucleic Acid Amplification Using Reversibly Modified Oligonucleotides | 毕万里 | 2016-08-10 | — | — | CN | disclosed |
| US-9045522-B2 | Nucleic acid amplification using a reversibly modified oligonucleotide | Bi, Wanli (US) | 2015-06-02 | — | — | US | disclosed |
| US-20130122507-A1 | Nucleic Acid Amplification Using A Reversibly Modified Oligonucleotide | SUZHOU NUHIGH BIOTECHNOLOGIES CO., LTD (CN) | 2013-05-16 | — | — | US | disclosed |
| US-8334099-B2 | Nucleic acid amplification using a reversibly modified oligonucleotide | BI WANLI (US) | 2012-12-18 | — | — | US | disclosed |
| EP-2049689-B1 | NUCLEIC ACID AMPLIFICATION USING A REVERSIBLY MODIFIED OLIGONUCLEOTIDE | BI WANLI (US) | 2011-12-21 | — | — | EP | disclosed |
| US-20100021970-A1 | Nucleic Acid Amplification Using a Reversibly Modified Oligonucleotide | BI WANLI | 2010-01-28 | — | — | US | disclosed |
| WO-1999024452-A9 | PYRIMIDINE DERIVATIVES FOR LABELED BINDING PARTNERS | ISIS PHARMACEUTICALS INC (US) | 1999-08-12 | — | — | WO | disclosed |
| EP-0923596-A2 | LIPOPHILIC OLIGONUCLEOTIDE ANALOGS | GILEAD SCIENCES, INC. (US) | 1999-06-23 | — | — | EP | disclosed |
| WO-1999024452-A2 | PYRIMIDINE DERIVATIVES FOR LABELED BINDING PARTNERS | ISIS PHARMACEUTICALS, INC. (US) | 1999-05-20 | — | — | WO | disclosed |
| WO-1998004575-A2 | LIPOPHILIC OLIGONUCLEOTIDE ANALOGS | GILEAD SCIENCES, INC. (US) | 1998-02-05 | — | — | WO | disclosed |
| WO-1997049723-A1 | CATIONIC LIPIDS FOR DELIVERY OF NUCLEIC ACID TO CELLS | GILEAD SCIENCES, INC. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1996001841-A1 | CATIONIC LIPIDS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS | GILEAD SCIENCES, INC. (US) | 1996-01-25 | — | — | WO | disclosed |
| WO-1996001840-A1 | CATIONIC LIPIDS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS | GILEAD SCIENCES, INC. (US) | 1996-01-25 | — | — | WO | disclosed |
| WO-1995029930-A2 | IMPROVED METHOD FOR OLIGONUCLEOTIDE ANALOG SYNTHESIS | GILEAD SCIENCES, INC. (US) | 1995-11-09 | — | — | WO | disclosed |